{
    "nct_id": "NCT04086966",
    "official_title": "PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study",
    "inclusion_criteria": "* Biopsy-proven treatment-na√Øve prostate adenocarcinoma with pelvic metastases known to suspected on standard-of-care staging imaging\n* Eligibility and plan to undergo definitive radiation therapy for prostate cancer per established standard-of-care radiation oncology clinical guidelines\n* Be at least 18 years of age\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Inability to tolerate or undergo PET/MRI or PET/CT\n* Previous or current hematologic or lymphatic disorder (including leukemia, lymphoma, Castleman's disease, etc.)\n* Recurrent prostate adenocarcinoma\n* Known distant metastatic disease\n* Current or prior treatment for prostate cancer\n* Known allergy to glucagon\n* Previous diagnosis of insulinoma or pheochromocytoma",
    "miscellaneous_criteria": ""
}